Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Biocatalysis and bioenergy [[electronic resource] /] / edited by Ching T. Hou and Jei-Fu Shaw
| Biocatalysis and bioenergy [[electronic resource] /] / edited by Ching T. Hou and Jei-Fu Shaw |
| Pubbl/distr/stampa | Hoboken, NJ, : John Wiley, c2009 |
| Descrizione fisica | 1 online resource (627 p.) |
| Disciplina | 660.6 |
| Altri autori (Persone) |
HouChing T <1935-> (Ching-Tsang)
ShawJei-Fu |
| Soggetto topico |
Biotechnology
Biomass energy Catalysis |
| Soggetto genere / forma | Electronic books. |
| ISBN |
1-281-76686-0
9786611766863 0-470-38586-3 1-60119-840-X 0-470-38585-5 |
| Classificazione |
CIT 647f
CIT 970f WF 9700 ZP 3760 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
BIOCATALYSIS AND BIOENERGY; CONTENTS; PREFACE; CONTRIBUTORS; PART I. BIODIESEL; 1. Fuel Properties and Performance of Biodiesel; 2. Enzymatic Reactions for Production of Biodiesel Fuel and Their Application to the Oil and Fat Industry; 3. Biodiesel Cost Optimizer: Least-Cost Raw Material Blending for Standardized Biodiesel Quality; 4. New Catalytic Systems for Vegetable Oil Transesterification Based on Tin Compounds; 5. Non-Catalytic Alcoholysis of Vegetable Oils for Production of Biodiesel Fuel; 6. Biodiesel from Acidulated Soapstock (Acid Oil); 7. Industrial Products from Biodiesel Glycerol
8. Development of New Products from Biodiesel Glycerin9. Optimization of Lipase-Catalyzed Biodiesel by Statistical Approach; 10. Production of Biofuel from Lipids and Alternative Resources; PART II. BIOETHANOL; 11. Biotechnology of Holocellulose-Degrading Enzymes; 12. From Biogas Energy to Keratinase Technology; 13. Emerging Technologies in Dry Grind Ethanol Production; 14. Gram-Positive Bacteria as Biocatalysts to Convert Biomass Derived Sugars into Biofuel and Chemicals; 15. Biological Hydrogen Production by Strict Anaerobic Bacteria: Fundamentals, Operational Strategies, and Limitations PART III. BIOCATALYSIS (PRODUCTS FROM RENEWABLE RESOURCES)16. Some Properties of a Self-Sufficient Cytochrome P-450 Monooxygenase System from Bacillus megaterium Strain ALA2; 17. Biocatalysis-based Development of Oligosaccharides in Japan; 18. Biocatalysis: Synthesis of Chiral Intermediates for Drugs; 19. Screening of Novel Microbial Enzymes and Their Application to Chiral Compound Production; 20. Hydrogenation Technologies for the Production of High Quantity of Biobeneficiary Conjugated Fatty Acids; 21. Production of Mannitol by Lactic Acid Bacteria: A Review 22. Evaluation of the Physiological Function of Docosahexaenoic Acid in Diet-induced Lipodystrophy Model Mice23. Conversion of Fishery By-products and Waste into Value-added Products: Ongoing Activity in Hokkaido, Japan; 24. Chemoenzymatic Synthesis of Enantiopure Triacylglycerols; 25. Biosynthesis of Castor Oil Studied by the Regiospecific Analysis of Castor Triacylglycerols by ESI-MS; 26. Composition, Functionality and Potential Applications of Seaweed Lipids; 27. Enzymatic Production of Marine-derived Protein Hydrolysates and Their Bioactive Peptides for Use in Foods and Nutraceuticals 28. Bioengineering and Application of Glucose Polymers29. Peroxidase-Catalyzed Polymerization of Phenolic Compounds Containing Carbohydrate Residues; 30. Production of Lipase and Oxygenated Fatty Acids from Vegetable Oils; 31. Production of Biologically Active Hydroxy Fatty Acids by Pseudomonas aeruginosa PR3; 32. Biotransformation of Oils to Value-added Compounds; INDEX |
| Record Nr. | UNINA-9910144134903321 |
| Hoboken, NJ, : John Wiley, c2009 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Biocatalysis and bioenergy [[electronic resource] /] / edited by Ching T. Hou and Jei-Fu Shaw
| Biocatalysis and bioenergy [[electronic resource] /] / edited by Ching T. Hou and Jei-Fu Shaw |
| Pubbl/distr/stampa | Hoboken, NJ, : John Wiley, c2009 |
| Descrizione fisica | 1 online resource (627 p.) |
| Disciplina | 660.6 |
| Altri autori (Persone) |
HouChing T <1935-> (Ching-Tsang)
ShawJei-Fu |
| Soggetto topico |
Biotechnology
Biomass energy Catalysis |
| ISBN |
1-281-76686-0
9786611766863 0-470-38586-3 1-60119-840-X 0-470-38585-5 |
| Classificazione |
CIT 647f
CIT 970f WF 9700 ZP 3760 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
BIOCATALYSIS AND BIOENERGY; CONTENTS; PREFACE; CONTRIBUTORS; PART I. BIODIESEL; 1. Fuel Properties and Performance of Biodiesel; 2. Enzymatic Reactions for Production of Biodiesel Fuel and Their Application to the Oil and Fat Industry; 3. Biodiesel Cost Optimizer: Least-Cost Raw Material Blending for Standardized Biodiesel Quality; 4. New Catalytic Systems for Vegetable Oil Transesterification Based on Tin Compounds; 5. Non-Catalytic Alcoholysis of Vegetable Oils for Production of Biodiesel Fuel; 6. Biodiesel from Acidulated Soapstock (Acid Oil); 7. Industrial Products from Biodiesel Glycerol
8. Development of New Products from Biodiesel Glycerin9. Optimization of Lipase-Catalyzed Biodiesel by Statistical Approach; 10. Production of Biofuel from Lipids and Alternative Resources; PART II. BIOETHANOL; 11. Biotechnology of Holocellulose-Degrading Enzymes; 12. From Biogas Energy to Keratinase Technology; 13. Emerging Technologies in Dry Grind Ethanol Production; 14. Gram-Positive Bacteria as Biocatalysts to Convert Biomass Derived Sugars into Biofuel and Chemicals; 15. Biological Hydrogen Production by Strict Anaerobic Bacteria: Fundamentals, Operational Strategies, and Limitations PART III. BIOCATALYSIS (PRODUCTS FROM RENEWABLE RESOURCES)16. Some Properties of a Self-Sufficient Cytochrome P-450 Monooxygenase System from Bacillus megaterium Strain ALA2; 17. Biocatalysis-based Development of Oligosaccharides in Japan; 18. Biocatalysis: Synthesis of Chiral Intermediates for Drugs; 19. Screening of Novel Microbial Enzymes and Their Application to Chiral Compound Production; 20. Hydrogenation Technologies for the Production of High Quantity of Biobeneficiary Conjugated Fatty Acids; 21. Production of Mannitol by Lactic Acid Bacteria: A Review 22. Evaluation of the Physiological Function of Docosahexaenoic Acid in Diet-induced Lipodystrophy Model Mice23. Conversion of Fishery By-products and Waste into Value-added Products: Ongoing Activity in Hokkaido, Japan; 24. Chemoenzymatic Synthesis of Enantiopure Triacylglycerols; 25. Biosynthesis of Castor Oil Studied by the Regiospecific Analysis of Castor Triacylglycerols by ESI-MS; 26. Composition, Functionality and Potential Applications of Seaweed Lipids; 27. Enzymatic Production of Marine-derived Protein Hydrolysates and Their Bioactive Peptides for Use in Foods and Nutraceuticals 28. Bioengineering and Application of Glucose Polymers29. Peroxidase-Catalyzed Polymerization of Phenolic Compounds Containing Carbohydrate Residues; 30. Production of Lipase and Oxygenated Fatty Acids from Vegetable Oils; 31. Production of Biologically Active Hydroxy Fatty Acids by Pseudomonas aeruginosa PR3; 32. Biotransformation of Oils to Value-added Compounds; INDEX |
| Record Nr. | UNINA-9910830428603321 |
| Hoboken, NJ, : John Wiley, c2009 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Biocatalysis and bioenergy / / edited by Ching T. Hou and Jei-Fu Shaw
| Biocatalysis and bioenergy / / edited by Ching T. Hou and Jei-Fu Shaw |
| Pubbl/distr/stampa | Hoboken, NJ, : John Wiley, c2009 |
| Descrizione fisica | 1 online resource (627 p.) |
| Disciplina | 660.6 |
| Altri autori (Persone) |
HouChing T <1935-> (Ching-Tsang)
ShawJei-Fu |
| Soggetto topico |
Biotechnology
Biomass energy Catalysis |
| ISBN |
1-281-76686-0
9786611766863 0-470-38586-3 1-60119-840-X 0-470-38585-5 |
| Classificazione |
CIT 647f
CIT 970f WF 9700 ZP 3760 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
BIOCATALYSIS AND BIOENERGY; CONTENTS; PREFACE; CONTRIBUTORS; PART I. BIODIESEL; 1. Fuel Properties and Performance of Biodiesel; 2. Enzymatic Reactions for Production of Biodiesel Fuel and Their Application to the Oil and Fat Industry; 3. Biodiesel Cost Optimizer: Least-Cost Raw Material Blending for Standardized Biodiesel Quality; 4. New Catalytic Systems for Vegetable Oil Transesterification Based on Tin Compounds; 5. Non-Catalytic Alcoholysis of Vegetable Oils for Production of Biodiesel Fuel; 6. Biodiesel from Acidulated Soapstock (Acid Oil); 7. Industrial Products from Biodiesel Glycerol
8. Development of New Products from Biodiesel Glycerin9. Optimization of Lipase-Catalyzed Biodiesel by Statistical Approach; 10. Production of Biofuel from Lipids and Alternative Resources; PART II. BIOETHANOL; 11. Biotechnology of Holocellulose-Degrading Enzymes; 12. From Biogas Energy to Keratinase Technology; 13. Emerging Technologies in Dry Grind Ethanol Production; 14. Gram-Positive Bacteria as Biocatalysts to Convert Biomass Derived Sugars into Biofuel and Chemicals; 15. Biological Hydrogen Production by Strict Anaerobic Bacteria: Fundamentals, Operational Strategies, and Limitations PART III. BIOCATALYSIS (PRODUCTS FROM RENEWABLE RESOURCES)16. Some Properties of a Self-Sufficient Cytochrome P-450 Monooxygenase System from Bacillus megaterium Strain ALA2; 17. Biocatalysis-based Development of Oligosaccharides in Japan; 18. Biocatalysis: Synthesis of Chiral Intermediates for Drugs; 19. Screening of Novel Microbial Enzymes and Their Application to Chiral Compound Production; 20. Hydrogenation Technologies for the Production of High Quantity of Biobeneficiary Conjugated Fatty Acids; 21. Production of Mannitol by Lactic Acid Bacteria: A Review 22. Evaluation of the Physiological Function of Docosahexaenoic Acid in Diet-induced Lipodystrophy Model Mice23. Conversion of Fishery By-products and Waste into Value-added Products: Ongoing Activity in Hokkaido, Japan; 24. Chemoenzymatic Synthesis of Enantiopure Triacylglycerols; 25. Biosynthesis of Castor Oil Studied by the Regiospecific Analysis of Castor Triacylglycerols by ESI-MS; 26. Composition, Functionality and Potential Applications of Seaweed Lipids; 27. Enzymatic Production of Marine-derived Protein Hydrolysates and Their Bioactive Peptides for Use in Foods and Nutraceuticals 28. Bioengineering and Application of Glucose Polymers29. Peroxidase-Catalyzed Polymerization of Phenolic Compounds Containing Carbohydrate Residues; 30. Production of Lipase and Oxygenated Fatty Acids from Vegetable Oils; 31. Production of Biologically Active Hydroxy Fatty Acids by Pseudomonas aeruginosa PR3; 32. Biotransformation of Oils to Value-added Compounds; INDEX |
| Record Nr. | UNINA-9910877089203321 |
| Hoboken, NJ, : John Wiley, c2009 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Industrial biotechnology [[electronic resource] ] : sustainable growth and economic success / / edited by Wim Soetaert and Erick J. Vandamme
| Industrial biotechnology [[electronic resource] ] : sustainable growth and economic success / / edited by Wim Soetaert and Erick J. Vandamme |
| Pubbl/distr/stampa | Weinheim, : Wiley-VCH, 2010 |
| Descrizione fisica | 1 online resource (523 p.) |
| Disciplina |
660.13
660.6 |
| Altri autori (Persone) |
SoetaertWim
VandammeErick J. <1943-> |
| Soggetto topico |
Biotechnology
Biotechnology - Social aspects |
| ISBN |
1-282-68661-5
9786612686610 3-527-63023-6 3-527-63024-4 |
| Classificazione |
CIT 900f
WF 9700 VN 8900 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Industrial Biotechnology: Sustainable Growth and Economic Success; Contents; Preface; List of Contributors; The Scope and Impact of Industrial Biotechnology; 1: History of Industrial Biotechnology; 1.1 Early History; 1.2 The Penicillin Story; 1.3 The Coming of the Cephalosporins; 1.4 The Waksman Era; 1.5 Strain Improvement; 1.6 Semi-Synthetic Antibiotics to Combat Resistant Microbes; 1.7 The Primary Metabolites; 1.7.1 Amino Acids; 1.7.2 Nucleotides; 1.7.3 Vitamins; 1.7.4 Organic Acids; 1.7.5 Alcohols; 1.7.6 Polymers
1.7.7 Specialty Sugars, Sugar Alcohols,L-Sugars, Oligosugars, Novel Extracellular Polysaccharides, Biopigments, Cosmetics Including Fragrants, and Microbial Enzymes for Chiral Synthesis and Other Applications1.8 The Shift from Antibiotics to Pharmacological Agents; 1.8.1 Enzyme Inhibitors; 1.8.2 Immunosuppressants; 1.8.3 Antitumor Agents; 1.8.4 Ergot Alkaloids; 1.8.5 Agricultural Compounds; 1.9 The Biopharmaceutical Revolution; 1.9.1 Human Insulin (Novolin, Humulin); 1.9.2 Erythropoietin (Epogen, Procrit); 1.9.3 Interferons; 1.9.4 Human Growth Hormone (Somatotropin, Somatropin Humatrope, Nutropin, Protropin, Somatren, Serostim)1.9.5 Tissue Plasminogen Activator (Activase, Alteplase); 1.9.6 Interleukins; 1.9.7 Factor VIII; 1.9.8 Colony-Stimulating Factors; 1.9.9 Human DNase (Pulmozyme); 1.9.10 Glucocerebrosidas (Cerezyme); 1.9.11 Monoclonal Antibodies; 1.9.12 Additional Biopharmaceuticals; 1.10 Recombinant Hosts; 1.10.1 E. coli; 1.10.2 Yeasts; 1.10.3 Molds; 1.10.4 Insect Cells; 1.10.5 Mammalian Cells; 1.10.6 Transgenic Animals; 1.10.7 Transgenic Plants; 1.11 Enzymes; 1.12 Bioconversions; 1.13 Vaccines; 1.14 Systems Microbiology; References 2: Industrial Systems Biology2.1 Introduction; 2.2 Industrial Biotechnology; 2.3 Market Drivers for Industrial Biotechnology; 2.4 Industrial Systems Biology; 2.5 Metabolic Models; 2.5.1 Microbial Metabolism-A Historical Perspective; 2.5.2 Genome Sequencing and Functional Genomics; 2.6 Reconstructed Metabolic Network Models; 2.6.1 Introduction; 2.6.2 Genome-Scale Reconstructed Network Process; 2.7 Industrial Systems Biology Case Studies; 2.7.1 A Mature and Developed Industrial Biotechnology Product: Bioethanol 2.7.2 A Recently Launched and Rapidly Growing Industrial Biotechnology Product: 1,3-Propanediol2.7.3 An In-Development Industrial Biotechnology Product: Succinic Acid; 2.8 Conclusion and Future Perspectives; References; 3: Fermentation Technology; 3.1 Introduction; 3.2 Types of Fermentations; 3.3 Fermentation Process; 3.3.1 Inoculum Generation; 3.3.2 Growth and Product Formation; 3.4 Fermentation Medium Design; 3.5 Sterilization of Air and Fermentation Medium; 3.6 Environmental Factors; 3.7 Fermentation Kinetics; 3.7.1 Batch Fermentation; 3.7.2 Continuous Culture; 3.8 Fermentation Equipment 3.8.1 Submerged Fermentation |
| Record Nr. | UNINA-9910140551803321 |
| Weinheim, : Wiley-VCH, 2010 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Industrial biotechnology [[electronic resource] ] : sustainable growth and economic success / / edited by Wim Soetaert and Erick J. Vandamme
| Industrial biotechnology [[electronic resource] ] : sustainable growth and economic success / / edited by Wim Soetaert and Erick J. Vandamme |
| Pubbl/distr/stampa | Weinheim, : Wiley-VCH, 2010 |
| Descrizione fisica | 1 online resource (523 p.) |
| Disciplina |
660.13
660.6 |
| Altri autori (Persone) |
SoetaertWim
VandammeErick J. <1943-> |
| Soggetto topico |
Biotechnology
Biotechnology - Social aspects |
| ISBN |
1-282-68661-5
9786612686610 3-527-63023-6 3-527-63024-4 |
| Classificazione |
CIT 900f
WF 9700 VN 8900 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Industrial Biotechnology: Sustainable Growth and Economic Success; Contents; Preface; List of Contributors; The Scope and Impact of Industrial Biotechnology; 1: History of Industrial Biotechnology; 1.1 Early History; 1.2 The Penicillin Story; 1.3 The Coming of the Cephalosporins; 1.4 The Waksman Era; 1.5 Strain Improvement; 1.6 Semi-Synthetic Antibiotics to Combat Resistant Microbes; 1.7 The Primary Metabolites; 1.7.1 Amino Acids; 1.7.2 Nucleotides; 1.7.3 Vitamins; 1.7.4 Organic Acids; 1.7.5 Alcohols; 1.7.6 Polymers
1.7.7 Specialty Sugars, Sugar Alcohols,L-Sugars, Oligosugars, Novel Extracellular Polysaccharides, Biopigments, Cosmetics Including Fragrants, and Microbial Enzymes for Chiral Synthesis and Other Applications1.8 The Shift from Antibiotics to Pharmacological Agents; 1.8.1 Enzyme Inhibitors; 1.8.2 Immunosuppressants; 1.8.3 Antitumor Agents; 1.8.4 Ergot Alkaloids; 1.8.5 Agricultural Compounds; 1.9 The Biopharmaceutical Revolution; 1.9.1 Human Insulin (Novolin, Humulin); 1.9.2 Erythropoietin (Epogen, Procrit); 1.9.3 Interferons; 1.9.4 Human Growth Hormone (Somatotropin, Somatropin Humatrope, Nutropin, Protropin, Somatren, Serostim)1.9.5 Tissue Plasminogen Activator (Activase, Alteplase); 1.9.6 Interleukins; 1.9.7 Factor VIII; 1.9.8 Colony-Stimulating Factors; 1.9.9 Human DNase (Pulmozyme); 1.9.10 Glucocerebrosidas (Cerezyme); 1.9.11 Monoclonal Antibodies; 1.9.12 Additional Biopharmaceuticals; 1.10 Recombinant Hosts; 1.10.1 E. coli; 1.10.2 Yeasts; 1.10.3 Molds; 1.10.4 Insect Cells; 1.10.5 Mammalian Cells; 1.10.6 Transgenic Animals; 1.10.7 Transgenic Plants; 1.11 Enzymes; 1.12 Bioconversions; 1.13 Vaccines; 1.14 Systems Microbiology; References 2: Industrial Systems Biology2.1 Introduction; 2.2 Industrial Biotechnology; 2.3 Market Drivers for Industrial Biotechnology; 2.4 Industrial Systems Biology; 2.5 Metabolic Models; 2.5.1 Microbial Metabolism-A Historical Perspective; 2.5.2 Genome Sequencing and Functional Genomics; 2.6 Reconstructed Metabolic Network Models; 2.6.1 Introduction; 2.6.2 Genome-Scale Reconstructed Network Process; 2.7 Industrial Systems Biology Case Studies; 2.7.1 A Mature and Developed Industrial Biotechnology Product: Bioethanol 2.7.2 A Recently Launched and Rapidly Growing Industrial Biotechnology Product: 1,3-Propanediol2.7.3 An In-Development Industrial Biotechnology Product: Succinic Acid; 2.8 Conclusion and Future Perspectives; References; 3: Fermentation Technology; 3.1 Introduction; 3.2 Types of Fermentations; 3.3 Fermentation Process; 3.3.1 Inoculum Generation; 3.3.2 Growth and Product Formation; 3.4 Fermentation Medium Design; 3.5 Sterilization of Air and Fermentation Medium; 3.6 Environmental Factors; 3.7 Fermentation Kinetics; 3.7.1 Batch Fermentation; 3.7.2 Continuous Culture; 3.8 Fermentation Equipment 3.8.1 Submerged Fermentation |
| Record Nr. | UNINA-9910830851103321 |
| Weinheim, : Wiley-VCH, 2010 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Industrial biotechnology : sustainable growth and economic success / / edited by Wim Soetaert and Erick J. Vandamme
| Industrial biotechnology : sustainable growth and economic success / / edited by Wim Soetaert and Erick J. Vandamme |
| Pubbl/distr/stampa | Weinheim, : Wiley-VCH, 2010 |
| Descrizione fisica | 1 online resource (523 p.) |
| Disciplina |
660.13
660.6 |
| Altri autori (Persone) |
SoetaertWim
VandammeErick J. <1943-> |
| Soggetto topico |
Biotechnology
Biotechnology - Social aspects |
| ISBN |
1-282-68661-5
9786612686610 3-527-63023-6 3-527-63024-4 |
| Classificazione |
CIT 900f
WF 9700 VN 8900 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Industrial Biotechnology: Sustainable Growth and Economic Success; Contents; Preface; List of Contributors; The Scope and Impact of Industrial Biotechnology; 1: History of Industrial Biotechnology; 1.1 Early History; 1.2 The Penicillin Story; 1.3 The Coming of the Cephalosporins; 1.4 The Waksman Era; 1.5 Strain Improvement; 1.6 Semi-Synthetic Antibiotics to Combat Resistant Microbes; 1.7 The Primary Metabolites; 1.7.1 Amino Acids; 1.7.2 Nucleotides; 1.7.3 Vitamins; 1.7.4 Organic Acids; 1.7.5 Alcohols; 1.7.6 Polymers
1.7.7 Specialty Sugars, Sugar Alcohols,L-Sugars, Oligosugars, Novel Extracellular Polysaccharides, Biopigments, Cosmetics Including Fragrants, and Microbial Enzymes for Chiral Synthesis and Other Applications1.8 The Shift from Antibiotics to Pharmacological Agents; 1.8.1 Enzyme Inhibitors; 1.8.2 Immunosuppressants; 1.8.3 Antitumor Agents; 1.8.4 Ergot Alkaloids; 1.8.5 Agricultural Compounds; 1.9 The Biopharmaceutical Revolution; 1.9.1 Human Insulin (Novolin, Humulin); 1.9.2 Erythropoietin (Epogen, Procrit); 1.9.3 Interferons; 1.9.4 Human Growth Hormone (Somatotropin, Somatropin Humatrope, Nutropin, Protropin, Somatren, Serostim)1.9.5 Tissue Plasminogen Activator (Activase, Alteplase); 1.9.6 Interleukins; 1.9.7 Factor VIII; 1.9.8 Colony-Stimulating Factors; 1.9.9 Human DNase (Pulmozyme); 1.9.10 Glucocerebrosidas (Cerezyme); 1.9.11 Monoclonal Antibodies; 1.9.12 Additional Biopharmaceuticals; 1.10 Recombinant Hosts; 1.10.1 E. coli; 1.10.2 Yeasts; 1.10.3 Molds; 1.10.4 Insect Cells; 1.10.5 Mammalian Cells; 1.10.6 Transgenic Animals; 1.10.7 Transgenic Plants; 1.11 Enzymes; 1.12 Bioconversions; 1.13 Vaccines; 1.14 Systems Microbiology; References 2: Industrial Systems Biology2.1 Introduction; 2.2 Industrial Biotechnology; 2.3 Market Drivers for Industrial Biotechnology; 2.4 Industrial Systems Biology; 2.5 Metabolic Models; 2.5.1 Microbial Metabolism-A Historical Perspective; 2.5.2 Genome Sequencing and Functional Genomics; 2.6 Reconstructed Metabolic Network Models; 2.6.1 Introduction; 2.6.2 Genome-Scale Reconstructed Network Process; 2.7 Industrial Systems Biology Case Studies; 2.7.1 A Mature and Developed Industrial Biotechnology Product: Bioethanol 2.7.2 A Recently Launched and Rapidly Growing Industrial Biotechnology Product: 1,3-Propanediol2.7.3 An In-Development Industrial Biotechnology Product: Succinic Acid; 2.8 Conclusion and Future Perspectives; References; 3: Fermentation Technology; 3.1 Introduction; 3.2 Types of Fermentations; 3.3 Fermentation Process; 3.3.1 Inoculum Generation; 3.3.2 Growth and Product Formation; 3.4 Fermentation Medium Design; 3.5 Sterilization of Air and Fermentation Medium; 3.6 Environmental Factors; 3.7 Fermentation Kinetics; 3.7.1 Batch Fermentation; 3.7.2 Continuous Culture; 3.8 Fermentation Equipment 3.8.1 Submerged Fermentation |
| Record Nr. | UNINA-9910877793403321 |
| Weinheim, : Wiley-VCH, 2010 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Modern biotechnology [[electronic resource] ] : connecting innovations in microbiology and biochemistry to engineering fundamentals / / Nathan S. Mosier, Michael R. Ladisch
| Modern biotechnology [[electronic resource] ] : connecting innovations in microbiology and biochemistry to engineering fundamentals / / Nathan S. Mosier, Michael R. Ladisch |
| Autore | Mosier Nathan S. <1974-> |
| Pubbl/distr/stampa | Wiley, : Hoboken, NJ, c2009 |
| Descrizione fisica | 1 online resource (461 p.) |
| Disciplina | 660.6 |
| Altri autori (Persone) | LadischMichael R. <1950-> |
| Soggetto topico |
Biotechnology
Chemical engineering |
| ISBN |
1-118-21020-4
1-282-30360-0 9786612303609 1-61344-162-2 0-470-47341-X 0-470-47340-1 |
| Classificazione |
BIO 250f
CHE 800f CIT 900f WF 9700 WF 9720 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
MODERN BIOTECHNOLOGY; CONTENTS; Preface; Acknowledgments; List of Illustrations; 1 Biotechnology; Introduction; The Directed Manipulation of Genes Distinguishes the New Biotechnology from Prior Biotechnology; Growth of the New Biotechnology Industry Depends on Venture Capital; Submerged Fermentations Are the Industry's Bioprocessing Cornerstone; Oil Prices Affect Parts of the Fermentation Industry; Growth of the Antibiotic/Pharmaceutical Industry; The Existence of Antibiotics Was Recognized in 1877; Penicillin Was the First Antibiotic Suitable for Human Systemic Use
Genesis of the Antibiotic Industry Other Antibiotics Were Quickly Discovered after the Introduction of Penicillin; Discovery and Scaleup Are Synergistic in the Development of Pharmaceutical Products; Success of the Pharmaceutical Industry in Research, Development, and Engineering Contributed to Rapid Growth but Also Resulted in Challenges; Growth of the Amino Acid/Acidulant Fermentation Industry; Production of Monosodium Glutamate (MSG) via Fermentation; The Impact of Glutamic Acid Bacteria on Monosodium Glutamate Cost Was Dramatic Auxotrophic and Regulatory Mutants Enabled Production of Other Amino Acids Prices and Volumes Are Inversely Related; Biochemical Engineers Have a Key Function in All Aspects of the Development Process for Microbial Fermentation; References; Homework Problems; 2 New Biotechnology; Introduction; Growth of the Biopharmaceutical Industry; The Biopharmaceutical Industry Is in the Early Part of Its Life Cycle; Discovery of Type II Restriction Endonucleases Opened a New Era in Biotechnology; The Polymerase Chain Reaction (PCR) Is an Enzyme-Mediated, In Vitro Amplification of DNA Impacts of the New Biotechnology on Biopharmaceuticals, Genomics, Plant Biotechnology, and Bioproducts Biotechnology Developments Have Accelerated Biological Research; Drug Discovery Has Benefited from Biotechnology Research Tools; The Fusing of Mouse Spleen Cells with T Cells Facilitated Production of Antibodies; Regulatory Issues Add to the Time Required to Bring a New Product to Market; New Biotechnology Methods Enable Rapid Identification of Genes and Their Protein Products; Genomics Is the Scientific Discipline of Mapping, Sequencing, and Analyzing Genomes Products from the New Plant Biotechnology Are Changing the Structure of Large Companies that Sell Agricultural Chemicals Bioproducts from Genetically Engineered Microorganisms Will Become Economically Important to the Fermentation Industry; References; Homework Problems; 3 Bioproducts and Biofuels; Introduction; Biocatalysis and the Growth of Industrial Enzymes; Glucose Isomerase Catalyzed the Birth of a New Process for Sugar Production from Corn; Identification of a Thermally Stable Glucose Isomerase and an Inexpensive Inducer Was Needed for an Industrial Process The Demand for High-Fructose Corn Syrup (HFCS) Resulted in Large-Scale Use of Immobilized Enzymes and Liquid Chromatography |
| Record Nr. | UNISA-996206390203316 |
Mosier Nathan S. <1974->
|
||
| Wiley, : Hoboken, NJ, c2009 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. di Salerno | ||
| ||
Modern biotechnology [[electronic resource] ] : connecting innovations in microbiology and biochemistry to engineering fundamentals / / Nathan S. Mosier, Michael R. Ladisch
| Modern biotechnology [[electronic resource] ] : connecting innovations in microbiology and biochemistry to engineering fundamentals / / Nathan S. Mosier, Michael R. Ladisch |
| Autore | Mosier Nathan S. <1974-> |
| Pubbl/distr/stampa | Wiley, : Hoboken, NJ, c2009 |
| Descrizione fisica | 1 online resource (461 p.) |
| Disciplina | 660.6 |
| Altri autori (Persone) | LadischMichael R. <1950-> |
| Soggetto topico |
Biotechnology
Chemical engineering |
| ISBN |
1-118-21020-4
1-282-30360-0 9786612303609 1-61344-162-2 0-470-47341-X 0-470-47340-1 |
| Classificazione |
BIO 250f
CHE 800f CIT 900f WF 9700 WF 9720 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
MODERN BIOTECHNOLOGY; CONTENTS; Preface; Acknowledgments; List of Illustrations; 1 Biotechnology; Introduction; The Directed Manipulation of Genes Distinguishes the New Biotechnology from Prior Biotechnology; Growth of the New Biotechnology Industry Depends on Venture Capital; Submerged Fermentations Are the Industry's Bioprocessing Cornerstone; Oil Prices Affect Parts of the Fermentation Industry; Growth of the Antibiotic/Pharmaceutical Industry; The Existence of Antibiotics Was Recognized in 1877; Penicillin Was the First Antibiotic Suitable for Human Systemic Use
Genesis of the Antibiotic Industry Other Antibiotics Were Quickly Discovered after the Introduction of Penicillin; Discovery and Scaleup Are Synergistic in the Development of Pharmaceutical Products; Success of the Pharmaceutical Industry in Research, Development, and Engineering Contributed to Rapid Growth but Also Resulted in Challenges; Growth of the Amino Acid/Acidulant Fermentation Industry; Production of Monosodium Glutamate (MSG) via Fermentation; The Impact of Glutamic Acid Bacteria on Monosodium Glutamate Cost Was Dramatic Auxotrophic and Regulatory Mutants Enabled Production of Other Amino Acids Prices and Volumes Are Inversely Related; Biochemical Engineers Have a Key Function in All Aspects of the Development Process for Microbial Fermentation; References; Homework Problems; 2 New Biotechnology; Introduction; Growth of the Biopharmaceutical Industry; The Biopharmaceutical Industry Is in the Early Part of Its Life Cycle; Discovery of Type II Restriction Endonucleases Opened a New Era in Biotechnology; The Polymerase Chain Reaction (PCR) Is an Enzyme-Mediated, In Vitro Amplification of DNA Impacts of the New Biotechnology on Biopharmaceuticals, Genomics, Plant Biotechnology, and Bioproducts Biotechnology Developments Have Accelerated Biological Research; Drug Discovery Has Benefited from Biotechnology Research Tools; The Fusing of Mouse Spleen Cells with T Cells Facilitated Production of Antibodies; Regulatory Issues Add to the Time Required to Bring a New Product to Market; New Biotechnology Methods Enable Rapid Identification of Genes and Their Protein Products; Genomics Is the Scientific Discipline of Mapping, Sequencing, and Analyzing Genomes Products from the New Plant Biotechnology Are Changing the Structure of Large Companies that Sell Agricultural Chemicals Bioproducts from Genetically Engineered Microorganisms Will Become Economically Important to the Fermentation Industry; References; Homework Problems; 3 Bioproducts and Biofuels; Introduction; Biocatalysis and the Growth of Industrial Enzymes; Glucose Isomerase Catalyzed the Birth of a New Process for Sugar Production from Corn; Identification of a Thermally Stable Glucose Isomerase and an Inexpensive Inducer Was Needed for an Industrial Process The Demand for High-Fructose Corn Syrup (HFCS) Resulted in Large-Scale Use of Immobilized Enzymes and Liquid Chromatography |
| Record Nr. | UNINA-9910139780703321 |
|
Mosier Nathan S. <1974->
|
||
| Wiley, : Hoboken, NJ, c2009 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Modern biotechnology : connecting innovations in microbiology and biochemistry to engineering fundamentals / / Nathan S. Mosier, Michael R. Ladisch
| Modern biotechnology : connecting innovations in microbiology and biochemistry to engineering fundamentals / / Nathan S. Mosier, Michael R. Ladisch |
| Autore | Mosier Nathan S. <1974-> |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | Wiley, : Hoboken, NJ, c2009 |
| Descrizione fisica | 1 online resource (461 p.) |
| Disciplina | 660.6 |
| Altri autori (Persone) | LadischMichael R. <1950-> |
| Soggetto topico |
Biotechnology
Chemical engineering |
| ISBN |
1-118-21020-4
1-282-30360-0 9786612303609 1-61344-162-2 0-470-47341-X 0-470-47340-1 |
| Classificazione |
BIO 250f
CHE 800f CIT 900f WF 9700 WF 9720 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
MODERN BIOTECHNOLOGY; CONTENTS; Preface; Acknowledgments; List of Illustrations; 1 Biotechnology; Introduction; The Directed Manipulation of Genes Distinguishes the New Biotechnology from Prior Biotechnology; Growth of the New Biotechnology Industry Depends on Venture Capital; Submerged Fermentations Are the Industry's Bioprocessing Cornerstone; Oil Prices Affect Parts of the Fermentation Industry; Growth of the Antibiotic/Pharmaceutical Industry; The Existence of Antibiotics Was Recognized in 1877; Penicillin Was the First Antibiotic Suitable for Human Systemic Use
Genesis of the Antibiotic Industry Other Antibiotics Were Quickly Discovered after the Introduction of Penicillin; Discovery and Scaleup Are Synergistic in the Development of Pharmaceutical Products; Success of the Pharmaceutical Industry in Research, Development, and Engineering Contributed to Rapid Growth but Also Resulted in Challenges; Growth of the Amino Acid/Acidulant Fermentation Industry; Production of Monosodium Glutamate (MSG) via Fermentation; The Impact of Glutamic Acid Bacteria on Monosodium Glutamate Cost Was Dramatic Auxotrophic and Regulatory Mutants Enabled Production of Other Amino Acids Prices and Volumes Are Inversely Related; Biochemical Engineers Have a Key Function in All Aspects of the Development Process for Microbial Fermentation; References; Homework Problems; 2 New Biotechnology; Introduction; Growth of the Biopharmaceutical Industry; The Biopharmaceutical Industry Is in the Early Part of Its Life Cycle; Discovery of Type II Restriction Endonucleases Opened a New Era in Biotechnology; The Polymerase Chain Reaction (PCR) Is an Enzyme-Mediated, In Vitro Amplification of DNA Impacts of the New Biotechnology on Biopharmaceuticals, Genomics, Plant Biotechnology, and Bioproducts Biotechnology Developments Have Accelerated Biological Research; Drug Discovery Has Benefited from Biotechnology Research Tools; The Fusing of Mouse Spleen Cells with T Cells Facilitated Production of Antibodies; Regulatory Issues Add to the Time Required to Bring a New Product to Market; New Biotechnology Methods Enable Rapid Identification of Genes and Their Protein Products; Genomics Is the Scientific Discipline of Mapping, Sequencing, and Analyzing Genomes Products from the New Plant Biotechnology Are Changing the Structure of Large Companies that Sell Agricultural Chemicals Bioproducts from Genetically Engineered Microorganisms Will Become Economically Important to the Fermentation Industry; References; Homework Problems; 3 Bioproducts and Biofuels; Introduction; Biocatalysis and the Growth of Industrial Enzymes; Glucose Isomerase Catalyzed the Birth of a New Process for Sugar Production from Corn; Identification of a Thermally Stable Glucose Isomerase and an Inexpensive Inducer Was Needed for an Industrial Process The Demand for High-Fructose Corn Syrup (HFCS) Resulted in Large-Scale Use of Immobilized Enzymes and Liquid Chromatography |
| Record Nr. | UNINA-9910818103403321 |
|
Mosier Nathan S. <1974->
|
||
| Wiley, : Hoboken, NJ, c2009 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||